TLR4 has been found to be upregulated in various types of cancer, including breast, ovarian, and colorectal cancers. This overexpression can contribute to tumor progression, metastasis, and resistance to chemotherapy. TLR4 signaling can promote a pro-tumorigenic environment by enhancing cell proliferation, angiogenesis, and immune evasion.
